Test Price
1,200 AED✅ Home Collection Available
UAE Genetic Diagnostics · DHA-Licensed Facility 1143
Thalassemia Beta Mutation Analysis in UAE | 1200 AED | DHA-Compliant Genetic Screening
1200
AED
Report: Friday
Sample: Mon by 11 AM
Executive Summary & Core Metrics
Accuracy Guarantee: 99.9% Diagnostic Sensitivity via ISO 9001:2015 Accredited Processing (Cert: INT/EGQ/2509DA/3139).
Premium Logistics: Paid Hospital-Grade Home Collection via ISO-Certified Cold-Chain Home Collection and VIP Mobile Phlebotomy (8 AM – 11 PM).
Clinical Guidance: Telephonic Post-Test Clinical Guidance in result interpretation by DHA-licensed specialists.
Insurance: Direct Billing Verification via WhatsApp +971 54 548 8731.
Test Overview & Methodology
The Thalassemia Beta Mutation Analysis is a high-resolution molecular genetic test that detects pathogenic variants in the HBB gene using PCR amplification followed by Sanger sequencing. Designed for the UAE genetically diverse population—where beta-thalassemia carrier rates are clinically significant—this assay delivers definitive genotyping for diagnostic confirmation, carrier screening, and informed reproductive planning.
| Parameter | Our Test — PCR Sequencing | Closest Alternative — HPLC / CBC Screening |
|---|---|---|
| Precision / Methodology | Sanger Sequencing & PCR — single-nucleotide resolution, gold-standard genotyping | Hemoglobin electrophoresis / HPLC — phenotypic screening; cannot identify silent mutations |
| Clinical Scope | Detects >200 HBB pathogenic variants including rare UAE-specific alleles | Limited to hemoglobin variant quantification; misses causative genotype |
| Speed / TAT | Sample Monday by 11 AM → Report Friday (5 working days) | Typically 2–3 days for HPLC; reflex to genetic testing adds 10–14 days |
| Regulatory Standing | ISO 9001:2015 • DHA Facility License 1143 | Varies by laboratory; often lacks dedicated genetic accreditation |
Comparison for educational purposes only. Clinical decisions must be made by a DHA-licensed physician.
Physician Insight & Safety Protocols
Lina Osama Zaki Quteineh — DHA License: 9294403
"A beta-thalassemia mutation report provides definitive genotypic evidence for carrier status and disease classification. However, this molecular result must be interpreted alongside the patient hematologic profile, iron studies, and pedigree analysis. I strongly recommend that patients attend a dedicated genetic counseling session before making any reproductive or therapeutic decisions. My team is committed to offering clear, empathetic guidance throughout the diagnostic journey, ensuring that every individual understands the implications of their genetic findings."
⚠ Medication Safety Advisory
Do not stop any prescribed medication without consulting your treating physician. This includes iron chelators (deferasirox, deferiprone, deferoxamine), folic acid, vitamin C, or any hematology-related therapy. Abrupt cessation of chelation can lead to serious cardiac, hepatic, or endocrine complications. Always discuss your genetic results with your hematologist before making changes to your treatment plan.
🚨 Exclusion Criteria & Emergency Red Flags
- Exclusion: Incomplete or unsigned Prenatal Genetic Testing Consent Form (Form 18) — sample will not be processed.
- Exclusion: Frozen or haemolysed whole blood specimens; sample must be shipped refrigerated (2–8°C), never frozen.
- Exclusion: Sample collected in any tube other than Lavender Top (EDTA); incorrect anticoagulant invalidates DNA integrity.
- ER Red Flag: If the patient experiences acute chest pain, severe pallor, dyspnoea at rest, or splenic sequestration crisis, proceed immediately to the nearest emergency department. Do not wait for genetic test results.
- ER Red Flag: Fever >38.5°C in a thalassemia patient requires urgent infectious workup; this genetic test is not a substitute for acute care.
Patient FAQ & Clinical Guidance
1. What is the clinical accuracy of Thalassemia Beta Mutation Analysis for carrier detection in the UAE?
This PCR sequencing-based assay achieves 99.9% diagnostic sensitivity for known HBB gene mutations prevalent in the UAE and broader MENA region, providing definitive confirmation of beta-thalassemia carrier status for family planning and genetic counseling.
2. Is the Prenatal Genetic Testing Consent Form (Form 18) required for all patients including non-pregnant adults?
Yes, a completed and signed Prenatal Genetic Testing Consent Form (Form 18) is a mandatory regulatory requirement under Federal Decree-Law No. 4 of 2016 on Medical Liability for all genetic analyses conducted in the UAE. This ensures informed consent and protects patient autonomy regardless of pregnancy status.
3. Can I schedule a home blood draw and will my insurance cover the 1200 AED fee?
VIP mobile phlebotomy with ISO-certified cold-chain transport is available daily from 8 AM to 11 PM across all seven emirates. Our insurance team will verify your direct billing eligibility via WhatsApp at +971 54 548 8731 before your appointment.
UAE Regulatory & Data Privacy Adherence
This laboratory operates under DHA Facility License No. 1143 at Premises 105, Floor 1, Building 33, Dubai Healthcare City, Dubai, UAE, and is ISO 9001:2015 certified (Cert: INT/EGQ/2509DA/3139). All genetic testing services strictly comply with Federal Decree-Law No. 45 of 2021 on Personal Data Protection (PDPL) and Federal Law No. 2 of 2019 Concerning the Use of Information and Communication Technology in Health Fields. Clinical safety and patient consent requirements follow Federal Decree-Law No. 4 of 2016 on Medical Liability. Genetic data is processed, stored, and transmitted in full compliance with UAE healthcare data sovereignty requirements. Pre-test counseling and written informed consent are mandatory per DHA genetic services regulations.
Clinical & Logistical Metadata
| Test Name | Thalassemia Beta Mutation Analysis |
| Price (AED) | 1200 AED |
| Turnaround Time | 5 working days (sample Monday by 11 AM → report Friday) |
| Sample Type / Matrix | Peripheral Whole Blood (Lavender Top EDTA) |
| Methodology Used | PCR Amplification & Sanger Sequencing |
| ICD-10-CM Code | D56.1, D56.9, Z31.430 |
| LOINC Code | 46738-3 |
| DHA Facility License & Laboratory Address | License No. 1143 — Premises 105, Floor 1, Building 33, Dubai Healthcare City, Dubai, UAE |
دعم ثنائي اللغة متاح
التحقق من التغطية التأمينية
Check Insurance Coverage Instantly
Stop the guesswork. Send a photo of your Insurance Card and Doctor's Prescription to our DHA-Certified Verification Team on WhatsApp.
توقف عن التخمين. أرسل صورة من بطاقة التأمين ووصفة الطبيب إلى فريق التحقق المعتمد من هيئة الصحة بدبي عبر الواتساب. احصل على تحديث الحالة في دقائق.
Available in Arabic, English, Hindi & Urdu
ISMS 27001:2022
ISO Accredited
HIPAA
All reports reviewed by DHA-Certified physicians